$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Ponatinib (ponatinib) Hong Kong version drug information, including indications, specifications and drug purchase channel instructions
2026-02-01 22:25:32
Check Details
Safinamide tablets’ marketing status, approval information and patient access information in China
2026-02-01 22:25:32
Check Details
Efficacy, indications and clinical research summary of Tarlatamab-Imdelltra in the treatment of small cell lung cancer
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS medication precautions and safety and risk tips for long-term use
2026-02-01 22:25:32
Check Details
Possible reactions after discontinuation of tovorafenib and instructions for medication risks and safe discontinuation protocols
2026-02-01 22:25:32
Check Details
How long does it take for vorasidenib-VORANIGO to take effect and analysis of clinical course of treatment, onset of effect and patient experience
2026-02-01 22:25:32
Check Details
Zongatinib (Zongatinib) mechanism of action, pharmacological effects and scientific principles in tumor treatment
2026-02-01 22:25:32
Check Details
Is vosoritide effective for achondroplasia? Analysis of clinical efficacy and patient height improvement data
2026-02-01 22:25:32
Check Details
Methylcobalamin injection (Rozebalamin) latest price reference and application of medical insurance reimbursement policy
2026-02-01 22:25:32
Check Details
Real evaluation of the therapeutic effect of cobimetinib and long-term patient follow-up data
2026-02-01 22:25:32
Check Details
How much does a box of macitentan cost after it is included in medical insurance? List of policy implementation areas
2026-02-01 22:25:32
Check Details
Detailed explanation of the mechanism of action of Tilorisen (Harcos) and its impact on the central arousal system
2026-02-01 22:25:32
Check Details
1
2
...
2431
2432
2433
2434
2435
2436
2437
2438
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
2
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
3
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
6
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
7
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
8
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
9
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
10
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
11
ROS and Cancer: The Potential of Natural Antioxidants
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment